Arrowhead Pharmaceuticals
ARWR
#2275
Rank
โ‚ฌ6.91 B
Marketcap
49,39ย โ‚ฌ
Share price
-1.49%
Change (1 day)
245.70%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): -1,12ย โ‚ฌ

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -1,09ย โ‚ฌ. an increase over its 2024 EPS that were of -4,35ย โ‚ฌ.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025-0,008709ย โ‚ฌ-99.8%
2024-4,35ย โ‚ฌ161.39%
2023-1,67ย โ‚ฌ17.36%
2022-1,42ย โ‚ฌ19.85%
2021-1,18ย โ‚ฌ61.9%
2020-0,73ย โ‚ฌ-216.67%
20190,63ย โ‚ฌ-210.77%
2018-0,57ย โ‚ฌ38.3%
2017-0,41ย โ‚ฌ-64.93%
2016-1,17ย โ‚ฌ-16.25%
2015-1,39ย โ‚ฌ28%
2014-1,09ย โ‚ฌ-3.85%
2013-1,13ย โ‚ฌ-31.58%
2012-1,65ย โ‚ฌ331.82%
2011-0,38ย โ‚ฌ-51.11%
2010-0,78ย โ‚ฌ-79.07%
2009-3,74ย โ‚ฌ-37.68%
2008-6,01ย โ‚ฌ-16.87%
2007-7,23ย โ‚ฌ38.33%
2006-5,23ย โ‚ฌ122.22%
2005-2,35ย โ‚ฌ42.11%
2004-1,65ย โ‚ฌ533.33%
2003-0,26ย โ‚ฌ-99.08%
2002-28,28ย โ‚ฌ25%
2001-22,62ย โ‚ฌ33.33%
2000-16,97ย โ‚ฌ-120.67%
199982,08ย โ‚ฌ-400%
1998-27,36ย โ‚ฌ-81.48%
1997-147,75ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
9,70ย โ‚ฌ-990.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-7,03ย โ‚ฌ 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
2,08ย โ‚ฌ-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
0,07838ย โ‚ฌ-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-2,51ย โ‚ฌ 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA